Gensight Biologics SA
PAR:SIGHT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gensight Biologics SA
PAR:SIGHT
|
FR |
|
G
|
Great Microwave Technology Co Ltd
SSE:688270
|
CN |
|
S
|
Sime Darby Bhd
KLSE:SIME
|
MY |
|
Leoch International Technology Ltd
HKEX:842
|
CN |
|
Chang Hwa Commercial Bank Ltd
TWSE:2801
|
TW |
|
Tongding Interconnection Information Co Ltd
SZSE:002491
|
CN |
|
Altia Consultores SA
MAD:ALC
|
ES |
|
F
|
Far Eastern University Inc
XPHS:FEU
|
PH |
|
G
|
Guangzhou Huayan Precision Machinery Co Ltd
SZSE:301138
|
CN |
|
B
|
BayCom Corp
NASDAQ:BCML
|
US |
|
Zhejiang Dingli Machinery Co Ltd
SSE:603338
|
CN |
Gensight Biologics SA
GenSight Biologics SA is a clinical-stage gene therapy company. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2016-07-13. The firm develops and commercializes gene therapy-based treatments of retinal degenerative diseases. The company develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness. The firm intends notably to develop a gene replacement therapy for Leber's hereditary optic neuropathy (LHON) and an optogenetic therapy for retinitis pigmentosa (RP).
GenSight Biologics SA is a clinical-stage gene therapy company. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2016-07-13. The firm develops and commercializes gene therapy-based treatments of retinal degenerative diseases. The company develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness. The firm intends notably to develop a gene replacement therapy for Leber's hereditary optic neuropathy (LHON) and an optogenetic therapy for retinitis pigmentosa (RP).
